Product Information
BISACODYL 10 MG SUPPOSITORY is a generic product labeled by Rising Pharma Holdings Inc., priced at $0.3197 per EA under NDC 57237032721. Its NADAC has been published 123 times since May 29, 2024.
The High Outlier badge above means this manufacturer's average price in the Bisacodyl market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
10 mg/1
Manufacturer
Rising Pharma Holdings Inc.NDC
57237032721
Classification
Generic
Dosage Form
SUPPOSITORY
Route
RECTAL
Effective Date
9/23/2026
Active Ingredients
BISACODYLApproval Type
OTC MONOGRAPH DRUG
FDA Application
M007On Market Since
8/24/2023
Pharmacological Classes
Price Statistics
The NADAC for BISACODYL 10 MG SUPPOSITORY has been published 123 times since May 29, 2024, and over the history we have for it it has risen 15.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.3197 per EA |
|---|---|
| All-time high | $0.3686 (Jun 10, 2026) |
| All-time low | $0.2775 (May 29, 2024) |
| 52-week high | $0.3686 |
| 52-week low | $0.3197 |
| Median price | $0.3335 |
| Average price | $0.3319 |
| Largest weekly change | +19.6% (Jun 19, 2024) |
| Weeks tracked | 123 |
| Tracking since | May 29, 2024 |
Generic Alternatives
The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Rising Pharma Holdings Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Bisacodyl market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Stimulant Laxative class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of BISACODYL 10 MG SUPPOSITORY?
The current National Average Drug Acquisition Cost (NADAC) for BISACODYL 10 MG SUPPOSITORY, manufactured by Rising Pharma Holdings Inc., is $0.3197 per EA (NDC 57237032721), effective Sep 30, 2026.
How has the price of BISACODYL 10 MG SUPPOSITORY changed over time?
Over the history we have for it, the NADAC for BISACODYL 10 MG SUPPOSITORY has risen 15.2%. It has been tracked across 123 weekly CMS publications since May 29, 2024.
What are the highest and lowest recorded NADAC prices for BISACODYL 10 MG SUPPOSITORY?
Since May 29, 2024, the NADAC for BISACODYL 10 MG SUPPOSITORY has ranged from a low of $0.2775 (May 29, 2024) to a high of $0.3686 (Jun 10, 2026), with a median of $0.3335 per EA.
Are there cheaper alternatives to BISACODYL 10 MG SUPPOSITORY?
5 manufacturers publish a NADAC-priced product with the same active ingredient and strength as BISACODYL 10 MG SUPPOSITORY in a comparable dosage form, but none are currently priced below it.
Who manufactures BISACODYL 10 MG SUPPOSITORY?
BISACODYL 10 MG SUPPOSITORY (NDC 57237032721) is labeled by Rising Pharma Holdings Inc., and CMS classifies it as a generic product.